Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Zoetis is a pet pharmaceutical company. Pfizer spun it...
— Daniel Shvartsman
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Zoetis Inc.
Zoetis ($ZTS) is a global leader in animal health, engaged in the discovery, development, and manufacture of veterinary pharmaceuticals, vaccines, and diagnostic products for livestock and companion animals. The manager divested...
Zoetis Inc. is a dominant player in the animal health industry, but its capital allocation strategy has focused on share buybacks rather than organic growth. The com...
Zoetis presents a tactical investment opportunity with potential for high short-term returns due to its aggressive capital allocation strategy. The company's h...
More institutional theses from Middle Coast Investing
CF Industries Holdings ($CF) is a leading North American manufacturer of nitrogen-based agricultural fertilizers and clean ammonia. Middle Coast established...
Tripadvisor ($TRIP) operates an online travel platform and booking marketplace, with its critical growth driver centered on Viator, an experiences and tour booking marketplace. While trimming shares...
Mobility Global ($MBGL), recently spun off from S&P Global, is a data intelligence and automotive software company whose core asset is Carfax, the industry-standard vehicle history database. The manager expanded...